Clinical Trials for Marker Therapeutics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Marker Therapeutics

Clinical Trials (3)

Safety of MT-401-OTS in Patients With Relapsed AML or MDS

PHASE1Recruiting

40 participants

Started: Jun 16, 2025 · Completed: Sep 30, 2029

2 conditions4 sponsors3 locations

MT-601 Administered To Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer

PHASE1Not yet recruiting

30 participants

Started: Sep 30, 2024 · Completed: Dec 31, 2027

1 condition1 sponsor0 locations

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

PHASE1Recruiting

79 participants

Started: Jan 2, 2023 · Completed: Feb 28, 2028

7 conditions1 sponsor7 locations